Michael P Horn
Overview
Explore the profile of Michael P Horn including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
33
Citations
469
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Andalucia C, Martinez-Prat L, Bentow C, Ann Aure M, Horn M, Mahler M
Diagnostics (Basel)
. 2023 Dec;
13(24).
PMID: 38132266
Anti-neutrophil cytoplasmic antibodies (ANCA) directed to proteinase 3 (PR3) represent highly established markers for patients with ANCA-associated vasculitis (AAV). PR3-ANCA have also demonstrated utility in the management of inflammatory bowel...
2.
Sokollik C, Pahud de Mortanges A, Leichtle A, Juillerat P, Horn M
Diagnostics (Basel)
. 2023 Aug;
13(15).
PMID: 37568854
Antibody testing in inflammatory bowel disease (IBD) can add to diagnostic accuracy of the main subtypes Crohn's disease (CD) and ulcerative colitis (UC). Whether modern modeling techniques such as supervised...
3.
Horn M, Nagler M
Praxis (Bern 1994)
. 2022 Aug;
111(11):592-596.
PMID: 35975408
CME: Rational Laboratory Diagnostics in the Context of COVID-19 In the management of COVID-19, a variety of laboratory tests are available to the general practitioner. The choice is difficult, and...
4.
Bitzenhofer M, Suter-Riniker F, Moor M, Sidler D, Horn M, Gschwend A, et al.
PLoS One
. 2022 Jun;
17(6):e0268780.
PMID: 35679232
Objectives: Although mRNA-based vaccines against SARS-CoV-2 induce a robust immune response and prevent infections and hospitalizations, there are limited data on the antibody response in individuals with humoral immunodeficiency. The...
5.
Sidler D, Born A, Schietzel S, Horn M, Aeberli D, Amsler J, et al.
RMD Open
. 2022 Apr;
8(1).
PMID: 35361691
Background: The majority of patients with B-cell-depleting therapies show compromised vaccination-induced immune responses. Herein, we report on the trajectories of anti-SARS-CoV-2 immune responses in patients of the RituxiVac study compared...
6.
Kolev M, Horn M, Semmo N, Nagler M
J Transl Autoimmun
. 2022 Mar;
5:100151.
PMID: 35309737
Clear guidance is needed in the development and implementation of laboratory biomarkers in medicine. So far, no standardized phased approach is established that would pilot researchers and clinicians in this...
7.
Schietzel S, Anderegg M, Limacher A, Born A, Horn M, Maurer B, et al.
RMD Open
. 2022 Feb;
8(1).
PMID: 35115385
Background: Immune responses on SARS-CoV-2 vaccination in patients receiving anti-CD20 therapies are impaired but vary considerably. We conducted a systematic review and meta-analysis of the literature on SARS-CoV-2 vaccine induced...
8.
Horn M, Jonsdottir H, Brigger D, Damonti L, Suter-Riniker F, Endrich O, et al.
Allergy
. 2022 Jan;
77(7):2090-2103.
PMID: 34986501
Background: Serological tests are a powerful tool in the monitoring of infectious diseases and the detection of host immunity. However, manufacturers often provide diagnostic accuracy data generated through biased studies,...
9.
Moor M, Suter-Riniker F, Horn M, Aeberli D, Amsler J, Moller B, et al.
Lancet Rheumatol
. 2021 Sep;
3(11):e789-e797.
PMID: 34514436
Background: B-cell-depleting therapies increase the risk of morbidity and mortality due to COVID-19. Evidence-based SARS-CoV-2 vaccination strategies for patients on B-cell-depleting therapies are scarce. We aimed to investigate humoral and...
10.
Zbaren N, Brigger D, Bachmann D, Helbling A, Jorg L, Horn M, et al.
J Allergy Clin Immunol
. 2021 Aug;
149(3):1018-1030.e11.
PMID: 34418424
Background: Clinical management of allergic diseases has been hampered by the lack of safe and convenient tests to reliably identify culprit allergens and to closely follow changes in disease activity...